But with ambitions to turn the cleantech start-up into a full-scale industrial engineering firm, the company has welcomed new ...

Completed a successful end of Phase 2 meeting with the FDA for bitopertin in erythropoietic protoporphyria (EPP), reaching alignment on all ...

EMA granted clearance to advancebelrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in ...

TechGlow 2024, a premier tech event, brought together industry leaders, academicians, and professionals to explore the intersection of technology, innovation, and culture. The event featured two panel ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS ®), today announced the acceptance of a poster titled "Noninvasive ... expectations concerning ENDRA ...

Office Space available at Rathangan Hall There is an office space available to rent at Rathangan Hall perfect for any small business with plenty of ... or email us at [email protected] ...

Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration with Twist Bioscience to design a novel antibody ...

Third Quarter, Recent Business Highlights and Upcoming Milestones Neurodegenerative ... has currently enrolled approximately 260 patients in the ASCENT clinical trials Poster presentation at CTAD 2024 ...

Welcome to the Absci Q3 2024 business update conference call ... As we recently announced, Absci is collaborating with Twist to design a novel antibody using generative AI. We are very excited to be ...

Snuggle in and get all relaxed with our picks of the best cozy games on Nintendo Switch, from Unpacking to Paleo Pines.

M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company has been awarded a $120,000 ...

Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration with Twist Bioscience to design a novel ... TL1A ...